Improved ruggedness of an ion‐pairing liquid chromatography/tandem mass spectrometry assay for the quantitative analysis of the triphosphate metabolite of a nucleoside reverse transcriptase inhibitor in peripheral blood mononuclear cells
- 26 December 2012
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 27 (3), 481-488
- https://doi.org/10.1002/rcm.6473
Abstract
RATIONALE Nucleotide analogs are highly polar and ionic, which impose great challenges on bioanalysis. Ion-pairing liquid chromatography/tandem mass spectrometry (LC/MS/MS) is the predominant reported approach for such compounds. Assay ruggedness of ion-pairing LC/MS/MS methods was often a challenge due to the potential contamination of the ion source of the mass spectrometer and LC column performance deterioration caused by ion-pairing reagents. METHODS An ion-pairing reagent was only added to the reconstitution solution to minimize its exposure to the MS ion source. To achieve optimum sensitivity, high pH mobile phases and negative ion ESI were needed for the LC/MS/MS method. However, high pH mobile phases led to the accumulation of ion-pairing reagent on the analytical column, which was washed off with an acidic solution to restore the column performance. In addition, isopropanol was used as a mobile phase modifier to improve peak shape and sensitivity. RESULTS The limit of detection was established at 1.0 ng/mL in the cell lysate. The calibration curve showed good linearity over the range of 1.0 to 100 ng/mL. The overall accuracy was no less than 87.7% based on four levels of quality control samples. Inter-run precision and intra-run precision across four analytical runs for low, geometric, medium and high QCs were less than 12.9. CONCLUSIONS By identifying and addressing the root cause of the assay ruggedness problem, we have developed a rugged ion-pairing LC/MS/MS method for a triphosphate (TP) metabolite of BMS-986001 in peripheral blood mononuclear cells. The new method overcame challenges such as a rapid deterioration of the peak shape, increased carryover and extremely poor column life. The peak shape was well maintained throughout multiple analytical runs. This method has been successfully applied to a toxicology study in cynomolgus monkey. Copyright © 2012 John Wiley & Sons, Ltd.This publication has 27 references indexed in Scilit:
- Mass spectrometry in the quantitative analysis of therapeutic intracellular nucleotide analogsMass Spectrometry Reviews, 2011
- Current status and challenges of antiretroviral research and therapyAntiviral Research, 2010
- HILIC LC‐MS for the determination of 2′‐C‐methyl‐cytidine‐triphosphate in rat liverJournal of Separation Science, 2009
- Nucleoside reverse transcriptase inhibitors and their phosphorylated metabolites in human immunodeficiency virus-infected human matricesJournal of Chromatography B, 2008
- Specificity enhancement with LC‐positive ESI‐MS/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear cellsJournal of Mass Spectrometry, 2007
- Simultaneous Quantitative Analysis of Metabolites Using Ion-Pair Liquid Chromatography−Electrospray Ionization Mass SpectrometryAnalytical Chemistry, 2006
- Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV InfectionAIDS Research and Human Retroviruses, 2004
- Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2002
- Simultaneous quantitation of the 5′-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometryJournal of the American Society for Mass Spectrometry, 2000
- A Systemic and Cellular Model for Zidovudine Plasma Concentrations and Intracellular Phosphorylation in PatientsThe Journal of Infectious Diseases, 1996